Industrial, Manufacturing & Heavy Industry Market News

Airway stent / lung stent market worth 105.6 million USD by 2022 according to new research report

Airway stent / lung stent market worth 105.6 million USD by 2022 according to new research report

The lung stents market is expected to reach USD 105.6 Million by 2022 from an estimated USD 76.3 Million in 2017, at a CAGR of 6.7%

- Advertising -

Browse 169 Market Data Tables and 36 Figures spread through 181 Pages and in-depth TOC on "Airway Stent / Lung Stent Market by Type (Tracheal, Laryngeal), Product (Self expandable, Balloon expandable), Material (Metal (Nitinol, Stainless Steel) Silicone, Hybrid), Procedure (Bronchoscopy (Rigid, Flexible), Laryngoscopy) - Global Forecast to 2022"
www.marketsandmarkets.com/Market-R…ket-32315890.html

“By product, the self-expandable stents segment accounted for the largest share of the lung stents market in 2016.”

On the basis of product, the self-expandable stents segment accounted for the largest share of the global lung stents market. The large share of this segment is due to their easy removability, decreased possibility of complications, and the higher adoption of this stents by intervention pulmonologists.

“By type, the tracheal stents segment accounted for the largest share of the lung stents market in 2016.”

On the basis of type, the tracheal stents segment accounted for the largest share of the global lung stents market.

- Advertising -

The large share of this segment is due to high incidence of lung cancer, increasing prevalence of chronic diseases such as COPD & asthma, rapid growth in the geriatric population, and improving healthcare affordability in developed countries.

“By material, the metal stents segment held the largest market share of lung stents market in 2016.”

Based on material, the metal stents segment accounted for the largest share of the lung stents market. The large share of this segment can be attributed to their ease of insertion, thinner walls as compared to silicone stents, a lower possibility of dislodgment or migration, and ability to adapt to the twisted airway.

“By procedure, the bronchoscopy segment held the largest market share of lung stents market in 2016.”

Based on procedure, the bronchoscopy segment accounted for the largest share of the lung stents market. The large share of this segment can be attributed to the wide application of bronchoscopy in the placement of stents during the treatment of airway/lung diseases.

Moreover, the adoption of bronchoscopy by healthcare providers is greater as compared to laryngoscopy.

“North America dominated the market in 2016.”

North America accounted for the largest share of the lung stents market in 2016, followed by Europe and Asia Pacific. The presence of a highly developed healthcare system, rising geriatric population, increasing incidence of lung cancer, quick adoption of new and innovative products, and a large number of lung stents manufacturing companies in this region are the major factors responsible for the large share of North America in the global lung stents market.

The prominent players in the global lung stents market are Boston Scientific (US), C.R. Bard (US), Teleflex (US), Cook Group (US), Merit Medical Systems (US), Novatech (France), Fuji Systems (Japan), Taewoong Medical (South Korea), ENDO-FLEX (Germany), M.I.Tech (South Korea), Micro-Tech (Nanjing) (China), EFER ENDOSCOPY  (France), Hood Laboratories (US), S&G BIOTECH (South Korea), Changzhou Health Microport Medical Device (China), and Kapitex Healthcare (UK).

 

News From

MarketsandMarkets™ - Business ResearchMarketsandMarkets™
Category: Market Research Publishers and RetailersCompany profile: MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies’ revenues. Currently servicing 5000 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets™ for their painpoints around revenues decisions. Our 850 fulltime analyst and SMEs at MarketsandMarkets™ are tracking global high growth ...